
Pro-Dex PDEX
€ 56.58
5.76%
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
3.23 B |
Marktkapitalisierung |
$ 205 B |
EBITDA (LTM) |
$ 14.6 M |
P/E (LTM) |
15.4425 |
P/S (LTM) |
2628.624163 |
EPS (LTM) |
4.0 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
Alcon
ALC
|
$ 77.31 | 6.83 % | $ 38.1 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 252.28 | 8.26 % | $ 14.4 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 8.63 | -0.46 % | $ 383 M | Nasdaq Global Market | ||
|
InfuSystem Holdings
INFU
|
$ 13.09 | 2.27 % | $ 270 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 133.88 | 5.94 % | $ 4.28 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 482.35 | 9.44 % | $ 172 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 64.37 | 5.82 % | $ 12.8 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.74 | 5.95 % | $ 275 M | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 241.09 | 6.17 % | $ 35.1 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.57 | 0.75 % | $ 17.1 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 27.22 | 8.14 % | $ 1.35 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 248.44 | 7.39 % | $ 24.4 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 8.39 | 16.04 % | $ 71.2 K | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 72.24 | 3.17 % | $ 234 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 409.01 | 0.5 % | $ 29.6 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.58 | 8.68 % | $ 2.11 B | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 26.39 | 3.51 % | $ 13.5 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.15 | 5.5 % | $ 52.7 M | Nasdaq Global Select Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Repro Med Systems
KRMD
|
$ 3.29 | 5.97 % | $ 152 M | Nasdaq Capital Market | ||
|
Teleflex Incorporated
TFX
|
$ 149.94 | 6.91 % | $ 6.69 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 65.46 | 8.36 % | $ 3.13 B | Nasdaq Global Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.25 | 4.39 % | $ 509 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 208.76 | 5.34 % | $ 60 B | NYSE,SPB | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Haemonetics Corporation
HAE
|
$ 128.59 | 6.91 % | $ 6.07 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 172.78 | 6.77 % | $ 4.26 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.31 | 2.45 % | $ 25.4 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 90.65 | 7.71 % | $ 5.36 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 3.26 | 0.62 % | $ 34.6 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 27.3 | 9.16 % | $ 4.59 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 87.9 | 9.05 % | $ 1.99 B | Nasdaq Global Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 56.96 | 9.12 % | $ 3.84 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 178.11 | -0.09 % | $ 10 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 0.95 | 12.8 % | $ 86.4 M | NYSE American | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |